Intellia Therapeutics issues equity awards to new hires under inducement plan
Intellia Therapeutics has granted restricted stock units to eight new employees as a direct incentive to join, using its 2024 Inducement Plan.
CRISPR Systems 2 articles
Programmable CRISPR-Cas machinery is the subject of CRISPR Systems: guide RNA targeting, Cas nucleases, PAM recognition, DNA or RNA cleavage, specificity engineering and screening applications all fit here. Coverage can compare Cas platforms or examine how system design changes editing behavior and off-target profiles. Base Editing and Prime Editing are separated because their defining mechanisms extend beyond standard nuclease action, even when a CRISPR-derived protein is part of the editor.
CRISPR therapy frees Berlin teen with beta-thalassaemia from transfusions
A 19-year-old in Berlin with beta-thalassaemia no longer needs blood transfusions after getting Casgevy, the first CRISPR gene-editing drug used in Germany.